Hand vs. wrist: which route to the heart is safer during a heart attack?
NCT ID NCT05605288
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This trial compares two ways to insert a catheter into the heart during a heart attack: through the wrist (conventional) or through the hand (distal). The goal is to see which method is faster and causes fewer complications, such as blocking the wrist artery. About 550 heart attack patients will take part, and doctors will measure procedure times and check for artery blockages before discharge.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If the hand approach works better, it could become the new standard for heart attack procedures, reducing complications like artery blockage.
- What could go wrong
- This is a single-center trial with 554 patients, so results may not apply to all hospitals or patients. The hand approach may be harder for doctors to perform.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
554 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age \> 18 years old * Indication: ST-Elevation Myocardial Infraction Exclusion Criteria: * Non-palpable radial artery * Previous CABG * Anatomical restrictions for forearm approach * Hemodynamic instability * Previous radial artery catheterization from the same arm during the last 30-days
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Cardiology, Centre Hospitalier Universitaire de Charleroi
Charleroi, Belgium
-
Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland.
Geneva, Switzerland
-
University Hospital of Patras
Pátrai, 26500, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- SMART-I: SiroMax™ Multi-Center coronary artery lesion treatment - safety and feasibility study of SiroMax SCB in ISR and DNSV
- AI & prehospital ECG analysis: a randomized controlled trial of a smartphone large language model for occlusion myocardial infarction detection by prehospital providers
- Hospital-to-Home transitional cardiac rehabilitation as a transition from Centre-Based cardiac rehabilitation after cardiac surgery: a Single-Blind randomised controlled trial
- Opportunistic screening of coronary artery calcium on Non-Gated routine chest CT using artificial intelligence: retrospective external validation and clinical risk stratification
- AI heart scan software aims to spot dangerous blockages without invasive probes
- A shot of nicorandil before stenting might keep blood flowing